{"disease":{"id":"paget-s-disease-of-bone","name":"paget s disease of bone"},"drugs":{"marketed":[{"drug_id":"calcitonin","indication_name":"Symptomatic Paget's disease of bone","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Osteobios","generic_name":"CALCITONIN","company_name":"Sanofi Aventis Us","drug_phase":"marketed","molecular_target":"calcitonin receptor","drug_class":"Calcitonin [EPC]","quality_score":70,"revenue":null,"mechanism":"Calcitonin salmon acts as a calcitonin receptor agonist, primarily affecting bone, with additional effects on the kidneys and gastrointestinal tract."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00774020","title":"Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT00740129","title":"Re-treatment of Participants With Paget's Disease Using Zoledronic Acid","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}